Corbus Pharmaceuticals Holdings (CRBP) Liabilities and Shareholders Equity (2013 - 2025)
Corbus Pharmaceuticals Holdings' Liabilities and Shareholders Equity was $168.2 million in Q4 2025, up 7.9% from $155.88 million a year earlier and up 53.6% from the prior quarter.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Liabilities and Shareholders Equity (2013 - 2025) Analysis & Trends
From Q4 2013 onward, Corbus Pharmaceuticals Holdings has reported Liabilities and Shareholders Equity for 47 quarters.
- Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 10.5% (FY2020 to FY2025).
- In earlier years, Liabilities and Shareholders Equity was $155.88 million in FY2024 (+451.4%), $28.27 million in FY2023 (-57.4%), $66.31 million in FY2022 (-38.4%) and $107.73 million in FY2021 (+5.3%).
- The Q4 2025 figure marks the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2013.
- Compared with a year earlier, Liabilities and Shareholders Equity was higher in six of the last eight quarters, with growth averaging 145.4%.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q4 2024 (growth of 451.4%); the worst was Q4 2023 (a decline of 57.4%).
- Per Business Quant data, CRBP's Liabilities and Shareholders Equity in the three quarters before Q4 2025 was $109.51 million (Q3 2025), $125.09 million (Q2 2025) and $139.93 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Corbus Pharmaceuticals Holdings | 52.74 Mn | -463.89 Mn | - | 168.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 168.20 Mn |
| Sep 30, 2025 | 109.51 Mn |
| Jun 30, 2025 | 125.09 Mn |
| Mar 31, 2025 | 139.93 Mn |
| Dec 31, 2024 | 155.88 Mn |
| Sep 30, 2024 | 164.17 Mn |
| Jun 30, 2024 | 151.98 Mn |
| Mar 31, 2024 | 125.74 Mn |
| Dec 31, 2023 | 28.27 Mn |
| Sep 30, 2023 | 36.28 Mn |
| Jun 30, 2023 | 43.72 Mn |
| Mar 31, 2023 | 51.65 Mn |
| Dec 31, 2022 | 66.31 Mn |
| Sep 30, 2022 | 73.83 Mn |
| Jun 30, 2022 | 82.07 Mn |
| Mar 31, 2022 | 95.68 Mn |
| Dec 31, 2021 | 107.73 Mn |
| Sep 30, 2021 | 119.57 Mn |
| Jun 30, 2021 | 120.61 Mn |
| Mar 31, 2021 | 140.15 Mn |
API Access
Corbus Pharmaceuticals Holdings Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();